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Herpes simplex virus (HSV) is a neurotropic virus that establishes lifelong latent infection in human ganglion sensory
neurons. This unique life cycle necessitates an intimate relation between the host defenses and virus counteractions
over the long course of infection. Two important aspects of host anti-viral defense, nuclear substructure restriction
and epigenetic chromatin regulation, have been intensively studied in the recent years. Upon viral DNA entering
the nucleus, components of discrete nuclear bodies termed nuclear domain 10 (ND10), converge at viral DNA and
place restrictions on viral gene expression. Meanwhile the infected cell mobilizes its histones and histone-associated
repressors to force the viral DNA into nucleosome-like structures and also represses viral transcription. Both anti-viral
strategies are negated by various HSV countermeasures. One HSV gene transactivator, infected cell protein 0 (ICP0),
is a key player in antagonizing both the ND10 restriction and chromatin repression. On one hand, ICP0 uses its E3
ubiquitin ligase activity to target major ND10 components for proteasome-dependent degradation and thereafter
disrupts the ND10 nuclear bodies. On the other hand, ICP0 participates in de-repressing the HSV chromatin by changing
histone composition or modification and therefore activates viral transcription. Involvement of a single viral protein in two
seemingly different pathways suggests that there is coordination in host anti-viral defense mechanisms and also
cooperation in viral counteraction strategies. In this review, we summarize recent advances in understanding the role of
chromatin regulation and ND10 dynamics in both lytic and latent HSV infection. We focus on the new
observations showing that ND10 nuclear bodies play a critical role in cellular chromatin regulation. We intend
to find the connections between the two major anti-viral defense pathways, chromatin remodeling and ND10
structure, in order to achieve a better understanding of how host orchestrates a concerted defense and how
HSV adapts with and overcomes the host immunity.
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Herpes simplex virus (HSV) is a member of family Her-
pesviridae, genus Simplexvirus. After the primary infec-
tion at oral, genital or ocular mucosa, HSV establishes
latency in ganglion sensory neurons. Periodically, HSV
reactivates and transmits through symptomatic or
asymptomatic shedding, causing an extensive spread of
this virus worldwide. Over 70 % of the world adult
population are seropositive for HSV, which marks HSV
as one of the most prevalent opportunistic pathogens
and the etiologic cause of a wide range of mild to severe
herpetic diseases including cold sores, stromal keratitis
and encephalitis.* Correspondence: haidong.gu@wayne.edu
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and its unique lytic-latent-lytic infection cycle warrant a
close relation and an intricate balance between HSV and
its host. In the case of HSV-1, the virus has a double-
stranded DNA genome of 152 kb, encoding more than
84 viral proteins [1]. The large viral genome gives HSV
adequate coding capacity to finely regulate the virus-
host interaction over a long course of infection. For
almost every aspect of human anti-viral defense systems,
be it on a single cell level or on a whole body surveil-
lance level, countermeasures have been found in the
HSV-1 infection. These properties make HSV-1 an ideal
model virus for understanding the relation between viral
replication and host defense mechanisms.
Chromatin-regulated gene repressions and nuclear do-
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certed host defense. HSV-1 employs multiple viral pro-
teins, especially an α (immediate early) gene product
called infected cell protein 0 (ICP0), to coordinate the
counteractions against the two anti-viral defenses. This
review focuses on the connections between the epigen-
etic regulation and ND10 dynamics. We will discuss the
recent advances that shed light on the coordination of
host defensive pathways and also the seemingly orches-
trated viral countermeasures.
Chromatin remodeling in lytic and latent HSV infection
In epigenetics, genes are activated or repressed through
changing the status of histones or nucleotide modifica-
tions (for reviews, see references [2, 3]). Therefore, cell
functions are modulated without changing the DNA se-
quences. Chromatin epigenetic regulation is one type of
host autonomous anti-viral response that mostly targets
against the DNA viruses. This intrinsic defense mechan-
ism mobilizes cellular histones and histone associated
complexes to quench viral transcription and replication.
Chromatin repression in lytic phase
Unlike other DNA viruses that can pack their virion ge-
nomes into minichromosomes to avoid being recognized
as foreign DNA [4, 5], HSV-1 does not contain histones
or histone-like proteins in the capsid [6]. Instead, early
studies showed that HSV-1 had polyamines in the virion
to neutralize the negative charges on viral DNA [7].
HSV-1 DNA is tightly confined within the capsid and
endures a pressure of about 20 atmospheres [8]. This
tremendous pressure drives a quick ejection of viral
DNA into the cell nucleus upon infection [9]. The sud-
den injection of mostly naked viral DNA inevitably trig-
gers an immediate alarm of foreign invasion. Indubitably
the infected cell mobilizes all defensive forces and at-
tempts to silence the viral DNA right away. One major
host cell defense against the incoming viral DNA is the
mobilization of histones and histone associated repres-
sors to force the viral DNA into chromatin repression.
Although the exact mechanism of how cells mobilize the
histone pool is not clear, it has been shown that histones
are more mobile after the HSV-1 infection [10–12]. At
least partial or unstable nucleosomes are formed in the
lytic infection, albeit unevenly across the viral genome
[13, 14].
The inhibitory effects of chromatin formation on viral
gene expression are reflected in several lines of evidence.
First, HSV-1 DNA was found to associate with histone
H3 as early as 1 h post infection [6]. Early in infection,
more histone association was found at β (delayed early)
and γ (late) gene promoters than that of α gene pro-
moters [6, 15]. Viral proteins such as VP16 and ICP0 are
responsible for the removal or remodeling of thehistones, which leads to the activation of viral gene ex-
pression (see below). The second observation that chro-
matin formation represses HSV-1 expression is the fact
that inhibitors targeting chromatin deactivating en-
zymes, such as histone deacetylases (HDACs) [16, 17],
promoted viral gene expression and DNA replication for
a recombinant HSV-1 containing a growth defect [18],
indicating the significance of the reversal of histone dea-
cetylation in lytic HSV-1 infection. The third evidence is
the demonstration of functional interactions between
HSV-1 proteins and chromatin repressors during the in-
fection. For example, a nuclear repressor complex
REST/CoREST/LSD1/HDAC was disrupted during the
HSV-1 infection by ICP0, a viral gene transactivator that
enhances downstream gene expression without any se-
quence specificity (for reviews, see [19, 20]), and then
later in infection, CoREST and HDAC1 were translo-
cated into the cytoplasm [21]. A dominant negative
CoREST interfering the CoREST-HDAC1 interaction
partially rescued viral replication in the absence of ICP0
[22], whereas the ICP0 mutant virus defective in CoR-
EST binding showed a growth defect and failed to
hyperacetylate the histone H3 and H4 bound to the qui-
escent DNA in a superinfection assay [23, 24]. ICP0 also
interacts with class II HDACs and the interaction is re-
sponsible for the relief of HDAC5-mediated gene repres-
sion [25]. ICP0 has a comprehensive role in both histone
removal and histone acetylation in lytic infection [26]. It
is capable of promoting a two-step heterochromatin re-
moval from the ICP8 promoter [27]. Interestingly, LSD1,
the histone demethylase in the REST/CoREST/LSD1/
HDAC complex, is required for early gene expression in
both lytic and latent HSV-1 infection [28]. Since histone
methylation status (mono-, di- or tri- methylation) plays
different roles in gene activation or repression [29], how
the inhibition of LSD1 changes histone methylation and
how different methylation status regulates the initial
HSV infection are not yet clear. Another viral protein,
tegument protein VP16, is responsible for excluding
histones from α gene promoters upon the viral DNA
entry [15]. VP16 recruits host cell factor 1 (HCF-1)
and Oct-1 to stimulate α promoter activity. This
immediate counteraction against chromatin repression
allows the expression of α genes, including ICP0
which further de-represses the HSV-1 chromatin on β
and γ promoters [20, 26], and ensures a full blown in-
fection. In consistent with these observations, newly
synthesized viral DNA is not chromatinized and is
well associated with RNA polymerase II and transcrip-
tion factors [6, 30].
Chromatin repression in latent phase
In latent HSV infection, all viral genes are turned off ex-
cept the latency-associated transcript (LAT), which is
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DNA exists as episomes in latently infected sensory
neurons [32, 33]. The viral DNA itself is not extensively
methylated [34, 35], but the typical nucleosome-
protected DNA pattern is readily observed for latent
DNA in micrococcal nuclease assays, suggesting that
latent viral DNA is packed into a nucleosomal structure
like the host chromatin [36]. The viral latent chromatin
is also regulated in a mechanism similar to that of the
host chromatin. For example, the histone H3K9 and
H3K14 at LAT promoter are hyperacetylated whereas
they are hypoacetylated at lytic promoters, consistent
with the fact that LAT is the only transcript made in la-
tency while all other viral expressions are repressed [35].
Furthermore, injection of HDAC inhibitor into latently
infected mice induces reactivation [37, 38], whereas
application of an inhibitor specifically blocking the de-
methylation of the repressive marker H3K27me3 reduces
reactivation in cultured neurons [39]. These findings
suggest that changes of histone modification status may
control the switch between latency and reactivation.
Interestingly, part of the LAT transcript is comple-
mentary to the C-terminal region of ICP0, the powerful
heterochromatin remover that stimulates lytic infection.
The promoters for LAT and ICP0 are only about 5 kb
away [1]. To set apart the euchromatin of LAT pro-
moter/enhancer region from the heterochromatin of
ICP0 promoter region in the latent infection, HSV
evolves to contain chromatin insulator CTCCC repeats
within the LAT intron, which recruits the CTCF protein
and marks the boundary between the euchromatin and
heterochromatin of latent HSV DNA [40].
Although in latent infection HSV genome DNA is
clearly packed into chromatin and HSV genes are fully
regulated through the host epigenetic machineries, the
processes of how chromatinization is initiated to estab-
lish latency and how chromatin repression is released to
reactivate from latency are largely unknown. The expres-
sion of LAT is very important for the HSV-1 latency,
which is reflected in two lines of evidence: (i) Deletion
of LAT expression resulted in a reduction of histone
H3K9me2 and H3K27me3, markers for inactive hetero-
chromatin, and an increase of histone H3K4me2, a
marker for active euchromatin, at the lytic promoters,
indicating the participation of LAT in regulating chro-
matinization at lytic promoters of HSV-1 [41, 42]; and
(ii) several microRNAs derived from the LAT region
inhibited the expression of ICP4 and ICP0, the two
major gene transactivators for lytic infection, suggesting
that LAT also regulates lytic expression on posttran-
scriptional level [43]. More interestingly, the lack of LAT
expression did not eliminate the presence of latent viral
DNA in mouse ganglia [38, 41, 44], but greatly reduced
the rate of spontaneous reactivation in infected animals[38, 45]. These results demonstrate that LAT expression
is not required in latency establishment but it is essen-
tial for latency reactivation. Although it is still unclear
how LAT is involved in stimulating the reactivation, it
is conceivable to postulate that LAT may monitor the
basal level expression of lytic genes by modulating the
chromatin status at lytic promoters and by controlling
the leaky transcription via microRNAs. Consequently,
LAT works to fine-tune the balance between latency
and reactivation.
Several chromatin repressor complexes are shown to
be important for either latency establishment or latency
reactivation. One of them is the aforementioned REST/
CoREST/LSD1/HDAC complex. Specific inhibition of
LSD1 blocked HSV-1 reactivation from latency [28, 46].
Another component from this complex, REST, plays a
critical role in latency establishment. Overexpression of
wild type REST in infected neuron caused a reduction in
reactivation from the explanted ganglia [47], whereas
overexpression of a dominant-negative REST capable of
binding to DNA but not to the other complex compo-
nents led to a failure in latency establishment [48]. A
second repressor complex has been implicated in latency
regulation is the polycomb group proteins including
polycomb repressor complexes (PRC) 1 and 2 [49, 50].
PRC1 component Bmi1 and PRC2 component Suz12
were each found on lytic promoters during latency by
two research groups [49, 50], but the results were not
reconciled with each other. A recent report showed that
histone phosphorylation by JNK pathway in the presence
of repressive methylation also contributed to the initi-
ation of latency reactivation [51]. How these different
pathways cooperate to control the reactivation switch is
still largely unknown.
ND10 nuclear bodies in the restriction of HSV infection
ND10s, also known as PML (promyelocytic leukemia)
nuclear bodies or PML oncogenic domains, are nuclear
structures that are composed of over 150 constituents
[52]. PML is the key organizer protein [53–55] for ND10
while many other ND10 components are only recruited
upon specific stimulations (for reviews, see references
[56]). ND10 is functionally promiscuous and has been
implicated in numerous cell functions including gene
regulation [57, 58], cell cycle arrest [59], apoptosis [60],
DNA repair [61], oncogenesis [55, 62], and anti-viral
defense [56]. The anti-viral effects of ND10 are initially
suggested by the following lines of evidence: (i) Interferon
(IFN) treatment increased the expression level of PML
and Sp100 and also the number and size of ND10 bodies
in treated cells [63, 64]. (ii) Disruption or distortion of the
ND10 structure is a common theme for many viral infec-
tions. For example, major ND10 constituents were found
degraded, which led to the dispersal of ND10 bodies, in
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[65, 66], whereas ND10 deformation and reorganization
were observed in adenovirus and papillomavirus infections
[67, 68], respectively. (iii) PML knockout mice were found
prone to infections [69]. Following an IFN treatment,
PML-/- fibroblasts failed to curtail viral replication to the
same extent as their PML+/+ counterparts [70, 71].
The relation between HSV-1 and ND10 during the
lytic infection is undoubtedly an intimate one. Upon
entry into the nucleus, HSV-1 viral DNA is first found
in the vicinity of ND10 bodies [72]. Although it remains
unclear whether this convergence of ND10 and viral
DNA directly causes the modulation of viral DNA, it is
quite evident that HSV-1 makes great efforts to destroy
the ND10 structures. ICP0, the immediate early protein
that promotes downstream viral expression, interacts
dynamically with the ND10 nuclear bodies [73]. Upon
synthesis, ICP0 is recruited to interact with ND10 [74].
Three proline-rich segments in the central region of
ICP0 facilitate ICP0 to fuse with the ND10 bodies so
that ICP0 can extensively comingle with the ND10 com-
ponents [75]. More importantly, ICP0 contains a RING-
type E3 ubiquitin ligase activity in its N-terminal region
[20]. The extensive interaction between ICP0 and ND10
components triggers the proteasome-dependent degrad-
ation of two major organizers of ND10, PML and Sp100
[65]. The degradation of ND10 organizers leads to a sub-
sequent dispersal of the ND10 bodies [76, 77]. The
dispersal of ND10 components is a key event in HSV-1
replication. When ICP0 is deleted, or when the E3
ubiquitin ligase of ICP0 is mutated, or when ICP0 fails
to enter ND10, ND10 persists at viral DNA and viral
replication is greatly demolished, especially at low multi-
plicity of infection [73, 78, 79]. Conversely, if ND10
components such as PML, Sp100, Daxx and ATRX are
depleted by siRNA knock-down, individually or in com-
bination, viral replication is significantly enhanced in the
absence of ICP0 [80–83]. Although the molecular mech-
anism of how ND10 regulates HSV replication is not
completely clear, recent discoveries suggest that ND10
may inhibit HSV-1 expression, at least in part, through
chromatin regulation.
Interconnection between ND10 and epigenetic regulation
ND10 nuclear bodies are also called PML oncogenic
domains because of the tumor suppressor function ini-
tially identified for PML. A t(15;17) chromosome trans-
location generates a PML-retinoic acid receptor α
(PML-RARα) chimeric fusion, which acts as a dominant-
negative PML to disrupt the ND10 structures. This is
the etiological cause for acute promyelocytic leukemia
(APL) [84]. All-trans retinoic acid (RA) treatment re-
stores the ND10 nuclear bodies that are disrupted by the
PML-RARα fusion and drives APL into remission [85].The connection between chromatin remodeling and
ND10 nuclear bodies has been proposed by many cell
biologists and cancer biologists, based on a series of ex-
perimental and clinical observations. First, various types
of histone modification enzymes, including acetyltrans-
ferases, deacetylases, and methyltransferases, have been
found to accumulate at ND10 [86–88]. A direct physical
interaction between PML and HDAC demonstrated by
Wu et al [87] also showed that an inhibition on gene ex-
pression was caused by the PML-HDAC association.
Furthermore, drugs inhibiting deacetylation by HDAC
or demethylation by LSD1 promoted RA differentiation
pathways via chromatin remodeling, which helped to dif-
ferentiate leukemia blasts that are resistant to the RA-
only treatment [89, 90]. The similar therapeutic effects
obtained from HDAC or LSD1 inhibition, which restores
the ND10 structure in APL patients, suggest that ND10
integrity and ND10 functions are regulated through
chromatin remodeling.
The second major indication that ND10 is closely
associated with chromatin regulation is the accumula-
tion of histone chaperones such as HIRA, Asf1 and
Daxx at ND10 [91, 92]. These chaperones participate in
the assembly and disassembly of nucleosomes and regu-
late the incorporation of histone variants to reprogram
the chromatin (for reviews, see references [93, 94]). The
localization of histone chaperone proteins at ND10 sug-
gests the involvement of ND10 in reassembling nucleo-
somes under various physiological conditions, such as
cell senescence or DNA damage repair [91, 95].
The third observation supporting a close ND10-
chromatin relation is the accumulation of numerous
chromatin regulators at ND10 or their direct interac-
tions with ND10 components. These regulators include
general repressive proteins such as heterochromatin pro-
tein 1 (HP1) [96], corepressor N-CoR, Sin3A [97] and
TIF1β [98], and general transcription activators such as
CBP [99], STAT3 [100], Sp1 [101] and HIPK2 [102], just
to name a few. The presence of these factors in the
dynamic ND10 depends on the cell type and cell physio-
logical status. The effects these factors may bring to the
cell also vary for different genes at a given time. One
interesting phenomenon stemmed from tethering re-
porter gene to ND10 [103]. When a SV40 promoter-
driven luciferase was targeted to ND10 the transgene
was repressed, but when a CMV promoter-driven lucif-
erase was targeted to ND10 it was activated. Moreover,
when ICP0 was co-expressed, the expression of both
tethered luciferase minigenes was elevated [103]. These
results suggest that (i) distinctive promoter sequences
are modulated differently by the various ND10 compo-
nents, and (ii) ICP0-targeted PML degradation and
ND10 dispersal can obscure the DNA sequence specifi-
city and put the DNA up for activation.
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As discussed in the previous sections, both chromatin
repression and ND10 nuclear bodies are regarded as
important parts of the host intrinsic anti-viral defense
mechanisms [21–24, 80–83]. A few lines of evidence
have shown that these two defenses interweave with
each other. ND10 restricts viral replication, at least par-
tially, through regulating the chromatin status of the
HSV genome.
In latently infected neurons, the number of HSV-1
genome loci varies from neuron to neuron, suggesting
the heterogeneity of latent infection [104]. In neurons
containing a single HSV-1 locus, the genome is wrapped
around by a donut-shaped ND10 body [105]. Although
current technologies have not been able to detect the
chromatin status of HSV genome in a single neuron, it is
plausible to postulate that ND10 components colocalized
to the latent HSV chromatin may regulate the intricate
balance between latency and reactivation. Interestingly, in
a cell culture model of quiescent HSV-1 infection, super-
infection by an ICP0 RING finger mutant virus, which
was incapable of degrading PML and Sp100 and therefore
incapable of dispersing ND10, did not remove heterochro-
matin markers from the quiescent HSV-1 genome,
whereas the wild type counterpart reduced the hetero-
chromatin markers on HSV-1 genome and reactivated the
quiescent genome into productive infection [24]. A recent
report in the HIV research showed that latent HIV-1 pro-
viruses are also in the close vicinity of ND10 loci in CD4+
T cells, with PML binding to the latent HIV-1 promoter
and forming facultative heterochromatin at HIV genome.
In addition, PML degradation and ND10 dispersal lead to
the loss of heterochromatin marker and the reactivation
of HIV-1 transcription [106]. Based on these findings, it is
quite reasonable to hypothesize that in latent infection
ND10 may also repress the HSV genome by reprogram-
ming the HSV chromatin.
In lytic infection, the incoming HSV genome is found
in the vicinity of ND10. Later on, viral replication com-
partments establish at the original ND10 loci after the
dispersal of ND10 [72, 107, 108]. Evidence to show that
ND10 components directly modulate the partial HSV
nucleosomes in early lytic infection is still lacking. How-
ever, various experiments have indicated a potential link
between ND10 repression and chromatin remodeling in
the lytic infection. First, from the virus side, two HSV-1
proteins have been found to attack ND10 and regulate his-
tone modification simultaneously. One is the aforemen-
tioned ICP0, which uses its RING type E3 ubiquitin ligase
to degrade ND10 organizers and in the meantime interacts
with CoREST to dislodge HDACs from the REST/CoR-
EST/LSD1/HDAC complex [26, 65, 79]. The two ICP0
functions are interconnected with each other. The D671A/E673A substitutions that knocks out the CoREST binding
also negatively affect the degradation of PML in the in-
fected cells [23]. The second viral protein regulating both
ND10 structure and chromatin remodeling is the γ1 (leaky
late) product US3. US3 is a viral serine/threonine kinase that
phosphorylates various cellular proteins to block apoptosis
during infection [109]. One class of the proteins phosphor-
ylated by US3 are HDACs, including HDAC1 and HDAC2
[110, 111]. HDAC phosphorylation affects its interactions
to its binding partners, such as CoREST, and therefore reg-
ulates gene expression in signal transduction and cell cycle
control [112]. Surprisingly, overexpression of US3 alone
disrupts ND10 in transfected cells [113], suggesting
that US3 may interact with some ND10 components. In
infected cells the time when US3 starts to express (3–
6 h post infection) overlaps with the time when degrad-
ation of PML and Sp100 is nearly completed. Whether
US3 participates in dispersing ND10 components has
not been investigated. It will be interesting to see if US3
phosphorylating HDAC and changing HSV chromatin
status are related to the ND10 dispersal.
The second notable connection between ND10 and
chromatin in HSV infection is the recruitment of various
cellular chromatin regulators into the ND10 bodies.
These proteins include the foreign DNA sensor IFI16,
the corepressor protein CoREST, and a histone acetyl-
transferase CLOCK [108, 114, 115]. IFI16 was another
repressive protein found to directly associate with the in-
coming HSV genome as early as 1 h post infection. This
association caused significant chromatin repression of
viral transcription whereas depletion of IFI16 released
the repression [116]. The aforementioned CoREST being
accumulated at ND10 was only observed in cells infected
by ICP0-null virus, suggesting that ICP0-CoREST-ND10
interactions are likely in dynamics. Later in HSV-1 infec-
tion the aggregated CoREST was also found as part of
the replication compartment [108], which may be in line
with the fact that LSD1, the demethylase tightly bound
to CoREST [117], is required for the HSV-1 replication
[28]. The CLOCK protein recruited to ND10 was found
beneficial for HSV-1 replication. The protein was stabi-
lized during the infection. Overexpression of CLOCK
promoted viral protein expression whereas depletion of
the protein significantly decreased viral protein expres-
sion [114], suggesting the participation of CLOCK in
HSV-1 gene activation.
So far, ND10 has been mainly viewed as a part of host
anti-viral defense. However, ND10 also contains many
gene activators and in reality it did activate CMV
promoter-driven luciferase tethered to ND10 [103].
Therefore, it is plausible to postulate that HSV may
adopt some positive factors located within ND10 in
order to establish its replication compartments, which
are initiated at the original ND10 loci [107, 108]. The
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involvement in viral replication and gene activation
strongly supports this hypothesis. Interestingly, the re-
cruitment of both CoREST and CLOCK involves their
interactions with ICP0 protein, directly or indirectly
[22, 114, 118], suggesting that ICP0 plays a critical role
in viral replication not only by disrupting the ND10
structure to alleviate restriction but also by capturing
useful ND10 components to stimulate replication.
Conclusions
Epigenetic regulation and ND10 dynamic organization
are two important aspects of host anti-viral defense
mechanisms. Between the two, ND10, with its massive
amount of component proteins moving in and out under
different conditions, may participate in and modulate
the chromatin remodeling process of HSV genome. Very
likely, this dynamic nuclear structure acts as a molecular
hub that both virus and host try to exploit the various
components for their own benefits. On one hand, the
host intends to bring the ND10 repressive components
to HSV genome and modulate the partial HSV nucleo-
somes for chromatin repression. On the other hand, be-
ing one of the best evolutionarily adapted viruses in
human history, HSV may use its multifunctional pro-
teins such as ICP0 to take advantage of this molecular
hub. It may try to recruit beneficial host proteins to the
spot while repelling the restrictive factors by destroying
ND10. Understanding the mechanisms of the coordin-
ation between different host defensive pathways and the
interaction of various viral countermeasures to these
host pathways is the key to solving the mysteries in her-
pes viral infection.
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